FDA Approval: CELLCEPT (MYCOPHENOLATE MOFETIL) — Type 1 - New Molecular Entity
Multi-specialty
Government source· FDAverify ↗HCPCS Level II code
—
No national Medicare fee schedule we hold prices J7517 — the Physician Fee Schedule lists it with status indicator E (2026 file). CMS fee schedules ↗
Code definition
Code
J7517
Code system
HCPCS Level II
Full description
Mycophenolate mofetil, oral, 250 mg
CLV Intelligence is tracking 2 policy changes that cite HCPCS J7517 most recently on 2026-08-04, drawn from 2 FDA notices. The changes span Multi-specialty. 1 is flagged critical or high priority.
Counts reflect the source documents CLV has matched to HCPCS J7517 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to J7517
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Multi-specialty
Government source· FDAverify ↗Search J7517 across all alerts
Full history of CMS and MAC policy changes matched to this code.
Audit documentation
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get alerts when policy changes affect J7517
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy